Medicated Shampoo Market Worth $14.8 Billion By 2025 | CAGR: 3.0%

The global medicated shampoo market size is expected to reach USD 14.8 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.0% over the forecast period. Rising concerns over hair related issues, growing consumer inclination towards hair maintenance, and new formulated product launches on a global level are projected to remain prominent market trends. Furthermore, rising awareness of maintaining beauty among working class adults in emerging economies including China, India, and Vietnam is projected to upscale the requirements of medicated shampoo over the next few years.

North America accounted for more than 30.0% share of the overall revenue in 2018. Strong foothold of hair care companies including Johnson & Johnson Consumer Inc. and Proctor & Gamble through extensive distribution networks in U.S. and Canada is expected to provide high market visibility of medicated shampoo. Furthermore, shifting inclination towards organic shampoo as a result of rising concerns over hazardous effects associated with the synthetically derived chemical ingredients is likely to force industry participants to incorporate natural extracts such as neem, strawberry, and other fruit flavors in the formulation of finished goods.

Dandruff and seborrheic dermatitis treatment generated a revenue of USD 3.1 billion in 2018. These products are used to remove the white flakes, reduce itchiness, and remove dead skin to give a clear and clean scalp. Rising concerns over anti-dandruff and excess oil control among the buyers have enabled the manufacturers to customize the products accordingly to meet desired specifications given by users.

Key industry participants include Procter & Gamble; Johnson & Johnson Consumer Inc.; Coty Inc.; Avalon Natural Products; Kao Corporation; Sanofi-Aventis Groupe; Himalaya Herbal Healthcare; and Summers Laboratories Inc. Product innovation is expected to remain a key strategy among the industry participants over the next few years.

In March 2017, Proctor & Gamble launched six-variants of anti-dandruff shampoos under the brand name, “Head & Shoulders Men Ultra”. These products are manufactured by using the high performance boosters including mint and caffeine, which are available in six variants including Total Care, Instant Scalp Relief, Max Oil Control, Hair Booster, Sports Fresh, and Old Spice.

 To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/medicated-shampoo-market

Further key findings from the study suggest:

• By treatment, psoriasis is expected to reach USD 2.5 billion by the end of 2025. The head lice treatment accounted for 21.5% share of the global medicated shampoo market revenue in 2018

• The online channel generated a revenue of USD 2.8 billion in 2018

• Asia Pacific is expected to witness the fastest CAGR of 3.5% from 2019 to 2025.

Grand View Research has segmented the global medicated shampoo market on the basis of treatment, distribution channel, and region:

Medicated Shampoo Treatment Outlook (Revenue, USD Billion, 2015 - 2025)

• Dandruff & Sebborheic Dermatis

• Psoriasis

• Tinea Captis

• Head Lice

• Allergic Reactions

Medicated Shampoo Distribution Channel Outlook (Revenue, USD Billion, 2015 - 2025)

• Hypermarkets/Supermarkets

• Convenience Stores

• Online

Medicated Shampoo Regional Outlook (Revenue, USD Billion, 2015 - 2025)

• North America

  • U.S.

• Europe

  • U.K.

  • Germany

• Asia Pacific

  • China

  • India

• Central & South America

  • Brazil

• Middle East & Africa

  • South Africa